US-guided tenotomy with PRP
Phase 3Small molecule
US-guided tenotomy with PRP is one of 5 small molecule programs targeting Epicondylitis. It is currently in Phase 3.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
9 competitors in Epicondylitis
#DrugCompanyPhaseTrials
1Aleve
Alnylam PharmaceuticalsApproved
Kenalog
BBausch Health Americas, Inc.
Approved
Xylocaine
MMEDRx USA, Inc.
Approved
Synera
ZZARS Pharma Inc.
Approved
US-guided tenotomy with PRP
JJose Ignacio Martin
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for US-guided tenotomy with PRP. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- JJose Ignacio Martin